GlassScriptPhysician profile
Randeep S Johl
NPI 1518349737
$1,665.72
in general payments reported to CMS, 2019-2025
16 companies · $677 in 2025
The $677 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.41 · 2021: $18.10 · 2022: $109 · 2023: $362 · 2024: $474 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $427.86 | 2022-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $380.25 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $333.63 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $93.78 | 2019-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.79 | 2024-2025 | Ofev |
| Exact Sciences Corporation | $66.31 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $54.56 | 2024 | Repatha |
| Scilex Pharmaceuticals INC. | $42.40 | 2022-2024 | |
| Amarin Pharma, INC. | $31.28 | 2023 | |
| Abbott Laboratories | $24.04 | 2025 | Freestyle Libre 3 |
| Qiagen, LLC | $23.59 | 2024 | |
| Xeris Pharmaceuticals, INC. | $21.89 | 2023 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $21.22 | 2023 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.81 | 2024 | Xifaxan |
| Alkermes, INC. | $18.10 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.21 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randeep Johl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.